EPA

Epa is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19347 references associated with EPA in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for EPA

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with EPA

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Sarcoma, Experimental D012513 13 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Hyperglycemia D006943 21 associated lipids
Per page 10 20 50 100 | Total 140

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with EPA

Download all related citations
Per page 10 20 50 100 | Total 4880
Authors Title Published Journal PubMed Link
Shahar E et al. Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease. The Atherosclerosis Risk in Communities Study Investigators. 1999 Am. J. Respir. Crit. Care Med. pmid:10351918
Meuillet EJ et al. Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2. 1999 Biochim. Biophys. Acta pmid:10354513
Nakamura N et al. Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. 1999 Int. J. Clin. Lab. Res. pmid:10356659
Kotkat HM et al. Effect of dietary fish oil (active EPA-30) on liver phospholipids in young and aged rats. 1999 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:10356759
Barichello JM et al. Enhanced rectal absorption of insulin-loaded Pluronic F-127 gels containing unsaturated fatty acids. 1999 Int J Pharm pmid:10361163
Morita I [Regulation of angiogenesis-expression of VEGF receptors]. 1998 Hum. Cell pmid:10363159
Bayorh MA et al. Enhanced nitric oxide synthesis reverses salt-induced alterations in blood flow and cGMP levels. 1999 Clin. Exp. Hypertens. pmid:10369379
Hussey HJ and Tisdale MJ Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid. 1999 Br. J. Cancer pmid:10376976
Madsen L and Berge RK 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. 1999 Lipids pmid:10380116
Katsumata T et al. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. 1999 Eur. J. Pharmacol. pmid:10395096